Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2001 May;54(5):340–347. doi: 10.1136/jcp.54.5.340

Autoantibodies and overlap syndromes in autoimmune rheumatic disease

E Jury 1, D D'Cruz 1, W Morrow 1
PMCID: PMC1731435  PMID: 11328831

Abstract

Many patients diagnosed with autoimmune rheumatic disease cannot be categorised easily into one of the established clinical entities such as systemic lupus erythematosus, dermatomyositis, or systemic sclerosis. The term "overlap syndrome" has been increasingly used to identify such patients and is useful in terms of clarifying prognosis and facilitating disease management. This article reviews overlap syndrome in autoimmune rheumatic disease, with particular emphasis on the associated serological markers.

Key Words: autoantibodies • overlap syndromes • autoimmune rheumatic disease

Full Text

The Full Text of this article is available as a PDF (133.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akimoto S., Ishikawa O., Muro Y., Takagi H., Tamura T., Miyachi Y. Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone. J Dermatol. 1999 Jan;26(1):18–22. doi: 10.1111/j.1346-8138.1999.tb03503.x. [DOI] [PubMed] [Google Scholar]
  2. Akimoto S., Ishikawa O., Takagi H., Miyachi Y. Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone. J Gastroenterol Hepatol. 1998 Sep;13(9):897–901. doi: 10.1111/j.1440-1746.1998.tb00758.x. [DOI] [PubMed] [Google Scholar]
  3. Akiyama Y., Tanaka M., Takeishi M., Adachi D., Mimori A., Suzuki T. Clinical, serological and genetic study in patients with CREST syndrome. Intern Med. 2000 Jun;39(6):451–456. doi: 10.2169/internalmedicine.39.451. [DOI] [PubMed] [Google Scholar]
  4. Alarcón-Segovia D. Mixed connective tissue disease and overlap syndromes. Clin Dermatol. 1994 Apr-Jun;12(2):309–316. doi: 10.1016/s0738-081x(94)90336-0. [DOI] [PubMed] [Google Scholar]
  5. Alarcón G. S. Unclassified or undifferentiated connective tissue disease. Baillieres Best Pract Res Clin Rheumatol. 2000 Mar;14(1):125–137. doi: 10.1053/berh.1999.0081. [DOI] [PubMed] [Google Scholar]
  6. Alderuccio F., Chan E. K., Tan E. M. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med. 1991 Apr 1;173(4):941–952. doi: 10.1084/jem.173.4.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Aragona P., Magazzù G., Macchia G., Bartolone S., Di Pasquale G., Vitali C., Ferreri G. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome. J Rheumatol. 1999 Jun;26(6):1306–1311. [PubMed] [Google Scholar]
  8. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  9. Bakri Hassan A., Rönnelid J., Gunnarsson I., Karlsson G., Berg L., Lundberg I. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease. J Autoimmun. 1998 Oct;11(5):503–508. doi: 10.1006/jaut.1998.0236. [DOI] [PubMed] [Google Scholar]
  10. Barakat S., Briand J. P., Abuaf N., van Regenmortel M. H., Muller S. Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera. Clin Exp Immunol. 1991 Oct;86(1):71–78. doi: 10.1111/j.1365-2249.1991.tb05776.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bennett R. M. Scleroderma overlap syndromes. Rheum Dis Clin North Am. 1990 Feb;16(1):185–198. [PubMed] [Google Scholar]
  12. Beutner E. H., Jablonska S., White D. B., Blaszczyk M., Chorzelski T. P., Cunningham R. K., Davis B. M. Dermatologic criteria for classifying the major forms of cutaneous lupus erythematosus: methods for systematic discriminant analysis and questions on the interpretation of findings. Clin Dermatol. 1992 Oct-Dec;10(4):443–456. doi: 10.1016/0738-081x(92)90090-l. [DOI] [PubMed] [Google Scholar]
  13. Blüthner M., Bautz E. K., Bautz F. A. Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries. J Immunol Methods. 1996 Nov 13;198(2):187–198. doi: 10.1016/s0022-1759(96)00160-3. [DOI] [PubMed] [Google Scholar]
  14. Brand C. A., Rowley M. J., Tait B. D., Muirden K. D., Whittingham S. F. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. Ann Rheum Dis. 1992 Feb;51(2):173–176. doi: 10.1136/ard.51.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bunn C. C., Black C. M. Systemic sclerosis: an autoantibody mosaic. Clin Exp Immunol. 1999 Aug;117(2):207–208. doi: 10.1046/j.1365-2249.1999.00990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Burdt M. A., Hoffman R. W., Deutscher S. L., Wang G. S., Johnson J. C., Sharp G. C. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999 May;42(5):899–909. doi: 10.1002/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  17. Buyon J. P. Neonatal lupus syndromes. Curr Opin Rheumatol. 1994 Sep;6(5):523–529. doi: 10.1097/00002281-199409000-00012. [DOI] [PubMed] [Google Scholar]
  18. Cervera R., Khamashta M. A., Hughes G. R. 'Overlap' syndromes. Ann Rheum Dis. 1990 Nov;49(11):947–948. doi: 10.1136/ard.49.11.947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chazouillères O., Wendum D., Serfaty L., Montembault S., Rosmorduc O., Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998 Aug;28(2):296–301. doi: 10.1002/hep.510280203. [DOI] [PubMed] [Google Scholar]
  20. Czaja A. J. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology. 1998 Aug;28(2):360–365. doi: 10.1002/hep.510280210. [DOI] [PubMed] [Google Scholar]
  21. Czaja A. J. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996 Oct 1;125(7):588–598. doi: 10.7326/0003-4819-125-7-199610010-00009. [DOI] [PubMed] [Google Scholar]
  22. Elagib K. E., Børretzen M., Jonsson R., Haga H. J., Thoen J., Thompson K. M., Natvig J. B. Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation. Clin Exp Immunol. 1999 Aug;117(2):388–394. doi: 10.1046/j.1365-2249.1999.00963.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Elagib K. E., Tengnér P., Levi M., Jonsson R., Thompson K. M., Natvig J. B., Wahren-Herlenius M. Immunoglobulin variable genes and epitope recognition of human monoclonal anti-Ro 52-kd in primary Sjögren's syndrome. Arthritis Rheum. 1999 Nov;42(11):2471–2481. doi: 10.1002/1529-0131(199911)42:11<2471::AID-ANR26>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
  24. Feist E., Kuckelkorn U., Dörner T., Dönitz H., Scheffler S., Hiepe F., Kloetzel P. M., Burmester G. R. Autoantibodies in primary Sjögren's syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum. 1999 Apr;42(4):697–702. doi: 10.1002/1529-0131(199904)42:4<697::AID-ANR12>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  25. Fine R. M. Overlap syndromes. Int J Dermatol. 1991 Jul;30(7):479–480. doi: 10.1111/j.1365-4362.1991.tb04865.x. [DOI] [PubMed] [Google Scholar]
  26. Fritzler M. J. Autoantibodies: diagnostic fingerprints and etiologic perplexities. Clin Invest Med. 1997 Feb;20(1):50–66. [PubMed] [Google Scholar]
  27. Fujikura S., Davis P. A., Prindiville T., Leung P., Fox R. I., Gershwin M. E. Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases. J Rheumatol. 1990 Nov;17(11):1453–1457. [PubMed] [Google Scholar]
  28. Fujimoto M., Sato S., Ihn H., Kikuchi K., Tamaki K., Takehara K. Autoantibodies to pyruvate dehydrogenase complex in patients with systemic sclerosis. Possible role of anti-E1 alpha antibody as a serologic indicator for development of primary biliary cirrhosis. Arthritis Rheum. 1995 Jul;38(7):985–989. doi: 10.1002/art.1780380715. [DOI] [PubMed] [Google Scholar]
  29. Garton M. J., Isenberg D. A. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases. Br J Rheumatol. 1997 Oct;36(10):1067–1074. doi: 10.1093/rheumatology/36.10.1067. [DOI] [PubMed] [Google Scholar]
  30. Gohlke F., Lohse A. W., Dienes H. P., Löhr H., Märker-Hermann E., Gerken G., Meyer zum Büschenfelde K. H. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol. 1996 Jun;24(6):699–705. doi: 10.1016/s0168-8278(96)80266-2. [DOI] [PubMed] [Google Scholar]
  31. Hamasaki K., Mimura T., Kanda H., Morino N., Yazaki Y., Nojima Y. Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibody. Lupus. 1997;6(9):734–736. doi: 10.1177/096120339700600910. [DOI] [PubMed] [Google Scholar]
  32. Harley J. B., Reichlin M., Arnett F. C., Alexander E. L., Bias W. B., Provost T. T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science. 1986 May 30;232(4754):1145–1147. doi: 10.1126/science.3458307. [DOI] [PubMed] [Google Scholar]
  33. Hassfeld W., Steiner G., Studnicka-Benke A., Skriner K., Graninger W., Fischer I., Smolen J. S. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum. 1995 Jun;38(6):777–785. doi: 10.1002/art.1780380610. [DOI] [PubMed] [Google Scholar]
  34. Hausmanowa-Petrusewicz I., Kowalska-Oledzka E., Miller F. W., Jarzabek-Chorzelska M., Targoff I. N., Blaszczyk-Kostanecka M., Jablonska S. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 1997 Jul;40(7):1257–1266. doi: 10.1002/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]
  35. Hida A., Kawabe Y., Kawakami A., Migita K., Tominaga M., Nakamura H., Eguchi K. HTLV-I associated Sjögren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren's syndrome. Ann Rheum Dis. 1999 May;58(5):320–322. doi: 10.1136/ard.58.5.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hoet R. M., Koornneef I., de Rooij D. J., van de Putte L. B., van Venrooij W. J. Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum. 1992 Oct;35(10):1202–1210. doi: 10.1002/art.1780351013. [DOI] [PubMed] [Google Scholar]
  37. Hoet R. M., Pieffers M., Stassen M. H., Raats J., de Wildt R., Pruijn G. J., van den Hoogen F., van Venrooij W. J. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. J Immunol. 1999 Sep 15;163(6):3304–3312. [PubMed] [Google Scholar]
  38. Hoffman R. W., Sharp G. C., Deutscher S. L. Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease. Arthritis Rheum. 1995 Dec;38(12):1837–1844. doi: 10.1002/art.1780381218. [DOI] [PubMed] [Google Scholar]
  39. Horiki T., Moriuchi J., Takaya M., Uchiyama M., Hoshina Y., Inada K., Inoko H., Tsuji K., Ichikawa Y. The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum. 1996 Jan;39(1):152–156. doi: 10.1002/art.1780390121. [DOI] [PubMed] [Google Scholar]
  40. Horiki T., Moriuchi J., Takaya M., Uchiyama M., Hoshina Y., Inada K., Inoko H., Tsuji K., Ichikawa Y. The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum. 1996 Jan;39(1):152–156. doi: 10.1002/art.1780390121. [DOI] [PubMed] [Google Scholar]
  41. Ioannou Y., Sultan S., Isenberg D. A. Myositis overlap syndromes. Curr Opin Rheumatol. 1999 Nov;11(6):468–474. [PubMed] [Google Scholar]
  42. Isenberg D., Black C. Naming names! Comment on the article by Smolen and Steiner. Arthritis Rheum. 1999 Jan;42(1):191–196. doi: 10.1002/1529-0131(199901)42:1<191::AID-ANR30>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  43. Johnson P. J., McFarlane I. G. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993 Oct;18(4):998–1005. doi: 10.1002/hep.1840180435. [DOI] [PubMed] [Google Scholar]
  44. Johnson S. W., North R. A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol. 1992 May;450:455–468. doi: 10.1113/jphysiol.1992.sp019136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Joplin R. E., Neuberger J. M. Immunopathology of primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 1999 Jun;11(6):587–593. doi: 10.1097/00042737-199906000-00002. [DOI] [PubMed] [Google Scholar]
  46. Kaplan M. M. Primary biliary cirrhosis. N Engl J Med. 1987 Feb 26;316(9):521–528. doi: 10.1056/NEJM198702263160907. [DOI] [PubMed] [Google Scholar]
  47. Kelekar A., Saitta M. R., Keene J. D. Molecular composition of Ro small ribonucleoprotein complexes in human cells. Intracellular localization of the 60- and 52-kD proteins. J Clin Invest. 1994 Apr;93(4):1637–1644. doi: 10.1172/JCI117145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Klein Gunnewiek J. M., van de Putte L. B., van Venrooij W. J. The U1 snRNP complex: an autoantigen in connective tissue diseases. An update. Clin Exp Rheumatol. 1997 Sep-Oct;15(5):549–560. [PubMed] [Google Scholar]
  49. Klein R., Zanger U. M., Berg T., Hopf U., Berg P. A. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol. 1999 Nov;118(2):290–297. doi: 10.1046/j.1365-2249.1999.01027.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Komatireddy G. R., Wang G. S., Sharp G. C., Hoffman R. W. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. J Rheumatol. 1997 Feb;24(2):319–322. [PubMed] [Google Scholar]
  51. LeRoy E. C., Maricq H. R., Kahaleh M. B. Undifferentiated connective tissue syndromes. Arthritis Rheum. 1980 Mar;23(3):341–343. doi: 10.1002/art.1780230312. [DOI] [PubMed] [Google Scholar]
  52. Lohse A. W., zum Büschenfelde K. H., Franz B., Kanzler S., Gerken G., Dienes H. P. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology. 1999 Apr;29(4):1078–1084. doi: 10.1002/hep.510290409. [DOI] [PubMed] [Google Scholar]
  53. Love L. A., Leff R. L., Fraser D. D., Targoff I. N., Dalakas M., Plotz P. H., Miller F. W. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991 Nov;70(6):360–374. doi: 10.1097/00005792-199111000-00002. [DOI] [PubMed] [Google Scholar]
  54. Maddison P. J. Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis. Ann Rheum Dis. 1991 Nov;50 (Suppl 4):887–893. doi: 10.1136/ard.50.suppl_4.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Maddison P. J. Mixed connective tissue disease: overlap syndromes. Baillieres Best Pract Res Clin Rheumatol. 2000 Mar;14(1):111–124. doi: 10.1053/berh.1999.0080. [DOI] [PubMed] [Google Scholar]
  56. Manns M. P. Recent developments in autoimmune liver diseases. J Gastroenterol Hepatol. 1997 Oct;12(9-10):S256–S271. doi: 10.1111/j.1440-1746.1997.tb00509.x. [DOI] [PubMed] [Google Scholar]
  57. Margaux J., Hayem G., Palazzo E., Chazerain P., De Bandt M., Haim T., Kahn M. F., Meyer O. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus. Rev Rhum Engl Ed. 1998 Jun;65(6):378–386. [PubMed] [Google Scholar]
  58. Marguerie C., Bunn C. C., Beynon H. L., Bernstein R. M., Hughes J. M., So A. K., Walport M. J. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990 Oct;77(282):1019–1038. doi: 10.1093/qjmed/77.1.1019. [DOI] [PubMed] [Google Scholar]
  59. Mayo M. J., Jenkins R. N., Combes B., Lipsky P. E. Association of clonally expanded T cells with the syndrome of primary biliary cirrhosis and limited scleroderma. Hepatology. 1999 Jun;29(6):1635–1642. doi: 10.1002/hep.510290637. [DOI] [PubMed] [Google Scholar]
  60. Miller F. W. Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies. JAMA. 1993 Oct 20;270(15):1846–1849. doi: 10.1001/jama.270.15.1846. [DOI] [PubMed] [Google Scholar]
  61. Mimori T., Akizuki M., Yamagata H., Inada S., Yoshida S., Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest. 1981 Sep;68(3):611–620. doi: 10.1172/JCI110295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Mimori T. Autoantibodies in connective tissue diseases: clinical significance and analysis of target autoantigens. Intern Med. 1999 Jul;38(7):523–532. doi: 10.2169/internalmedicine.38.523. [DOI] [PubMed] [Google Scholar]
  63. Mimori T. Structures targeted by the immune system in myositis. Curr Opin Rheumatol. 1996 Nov;8(6):521–527. doi: 10.1097/00002281-199611000-00005. [DOI] [PubMed] [Google Scholar]
  64. Mimori T. Structures targeted by the immune system in myositis. Curr Opin Rheumatol. 1996 Nov;8(6):521–527. doi: 10.1097/00002281-199611000-00005. [DOI] [PubMed] [Google Scholar]
  65. Moutsopoulos H. M., Manoussakis M. N. Lumping or splitting autoimmune rheumatic disorders? Lessons from Sjögren's syndrome. Br J Rheumatol. 1998 Dec;37(12):1263–1264. doi: 10.1093/rheumatology/37.12.1263. [DOI] [PubMed] [Google Scholar]
  66. Nimelstein S. H., Brody S., McShane D., Holman H. R. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 1980 Jul;59(4):239–248. [PubMed] [Google Scholar]
  67. O'Neill T. W., Maddison P. J. Rheumatoid arthritis associated with myositis and anti-Jo-1 antibody. J Rheumatol. 1993 Jan;20(1):141–143. [PubMed] [Google Scholar]
  68. Plotz P. H. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet. 1983 Oct 8;2(8354):824–826. doi: 10.1016/s0140-6736(83)90740-7. [DOI] [PubMed] [Google Scholar]
  69. Powell F. C., Schroeter A. L., Dickson E. R. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med. 1987 Jan;62(237):75–82. [PubMed] [Google Scholar]
  70. Praprotnik S., Bozic B., Kveder T., Rozman B. Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective study. Clin Exp Rheumatol. 1999 Jan-Feb;17(1):63–68. [PubMed] [Google Scholar]
  71. Ramos-Casals M., García-Carrasco M., Cervera R., Font J. Sjögren's syndrome and hepatitis C virus. Clin Rheumatol. 1999;18(2):93–100. doi: 10.1007/s100670050064. [DOI] [PubMed] [Google Scholar]
  72. Reeves W. H., Satoh M. Features of autoantigens. Mol Biol Rep. 1996;23(3-4):217–226. doi: 10.1007/BF00351172. [DOI] [PubMed] [Google Scholar]
  73. Reichlin M., Maddison P. J., Targoff I., Bunch T., Arnett F., Sharp G., Treadwell E., Tan E. M. Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol. 1984 Jan;4(1):40–44. doi: 10.1007/BF00915286. [DOI] [PubMed] [Google Scholar]
  74. Ricchiuti V., Briand J. P., Meyer O., Isenberg D. A., Pruijn G., Muller S. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera. Clin Exp Immunol. 1994 Mar;95(3):397–407. doi: 10.1111/j.1365-2249.1994.tb07010.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Satoh T., Hirakata M., Yoshida T., Matsumura M., Miyachi K., Mimori T., Akizuki M. Systemic lupus erythmatosus associated with autoimmune hepatitis two cases with novel autoantibodies to transfer RNA-related antigens. Clin Rheumatol. 1997 May;16(3):305–309. doi: 10.1007/BF02238968. [DOI] [PubMed] [Google Scholar]
  76. Scofield R. H., Farris A. D., Horsfall A. C., Harley J. B. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum. 1999 Feb;42(2):199–209. doi: 10.1002/1529-0131(199902)42:2<199::AID-ANR1>3.0.CO;2-1. [DOI] [PubMed] [Google Scholar]
  77. Sharp G. C., Hoffman R. W. Clinical, immunologic, and immunogenetic evidence that mixed connective tissue disease is a distinct entity: comment on the article by Smolen and Steiner. Arthritis Rheum. 1999 Jan;42(1):190–196. doi: 10.1002/1529-0131(199901)42:1<190::AID-ANR29>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  78. Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972 Feb;52(2):148–159. doi: 10.1016/0002-9343(72)90064-2. [DOI] [PubMed] [Google Scholar]
  79. Smolen J. S., Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum. 1998 May;41(5):768–777. doi: 10.1002/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  80. Steiner G., Skriner K., Hassfeld W., Smolen J. S. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD. Mol Biol Rep. 1996;23(3-4):167–171. doi: 10.1007/BF00351165. [DOI] [PubMed] [Google Scholar]
  81. Steiner G., Skriner K., Smolen J. S. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases. Int Arch Allergy Immunol. 1996 Dec;111(4):314–319. doi: 10.1159/000237386. [DOI] [PubMed] [Google Scholar]
  82. Strassburg C. P., Jaeckel E., Manns M. P. Anti-mitochondrial antibodies and other immunological tests in primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 1999 Jun;11(6):595–601. doi: 10.1097/00042737-199906000-00003. [DOI] [PubMed] [Google Scholar]
  83. TUFFANELLI D. L., WINKELMANN R. K. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol. 1961 Sep;84:359–371. doi: 10.1001/archderm.1961.01580150005001. [DOI] [PubMed] [Google Scholar]
  84. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  85. Tominaga M., Migita K., Nakamura H., Ichinose Y., Furuya T., Origuchi T., Kawabe Y., Hida A., Nakamura T., Eguchi K. Expression of metalloproteinase-2 (gelatinase A) in labial salivary glands of patients with Sjögren's syndrome with HTLV-I infection. Clin Exp Rheumatol. 1999 Jul-Aug;17(4):463–466. [PubMed] [Google Scholar]
  86. Topfer F., Gordon T., McCluskey J. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):875–879. doi: 10.1073/pnas.92.3.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Tubach F., Hayem G., Elias A., Nicaise P., Haim T., Kahn M. F., Meyer O. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma. Rev Rhum Engl Ed. 1997 Jun;64(6):362–367. [PubMed] [Google Scholar]
  88. Venables P. J. Polymyositis-associated overlap syndromes. Br J Rheumatol. 1996 Apr;35(4):305–306. doi: 10.1093/rheumatology/35.4.305. [DOI] [PubMed] [Google Scholar]
  89. Williams H. J., Alarcón G. S., Neuner R., Steen V. D., Bulpitt K., Clegg D. O., Ziminski C. M., Luggen M. E., Polisson R. P., Willkens R. F. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. J Rheumatol. 1998 Feb;25(2):261–268. [PubMed] [Google Scholar]
  90. Wilson R. W., Provost T. T., Bias W. B., Alexander E. L., Edlow D. W., Hochberg M. C., Stevens M. B., Arnett F. C. Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum. 1984 Nov;27(11):1245–1253. doi: 10.1002/art.1780271106. [DOI] [PubMed] [Google Scholar]
  91. Yamanishi Y., Maeda H., Katayama S., Ishioka S., Yamakido M. Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation. J Rheumatol. 1996 Nov;23(11):1991–1994. [PubMed] [Google Scholar]
  92. von Mühlen C. A., Tan E. M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995 Apr;24(5):323–358. doi: 10.1016/s0049-0172(95)80004-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES